Joseph E. Gilligan

Represented Life Storage in its successful defense of a hostile takeover attempt and subsequent US$12.7bn friendly merger with Extra Space Storage creating a US$47bn enterprise value company.

Represented Novartis AG in its acquisition of Chinook Therapeutics for up to US$3.5bn, including US$300m of contingent value rights (CVRs).

Represented Novartis AG in its US$8.7bn acquisition of AveXis Inc., a gene therapy company.

Represented Transurban in its US$2.1bn sale of a 50 percent interest in its Transurban Chesapeake assets, including multiple toll roads. 

Represented the 3M Company in various transactions, including its US$1.037bn acquisition of the Polypore separations media business and the US$850m sale of its biometrics business.

Represented GE Healthcare in its proposed acquisition of Thermo Fisher's cell culture and gene modulation business for approximately US$1.06bn.

Represented Colonial Properties Trust in its US$8.6bn merger with Mid-America Apartment Communities Inc.

Represented Orthofix Medical in its US$830m merger-of-equals business combination with SeaSpine Holdings.

Represented GE Healthcare in its acquisition of SeqWright Inc., a provider of nucleic acid sequencing and other genomic services.

Represented Dun & Bradstreet in various transactions, including its acquisitions of NetProspex and Avention.

Represented the Transaction Committee of the Board of Directors of Knology Inc. in its US$1.5bn acquisition by WOW! Internet, Cable & Phone.

Represented PAETEC Holding Corp. in its US$2.3bn merger with Windstream Corp.

Represented NextEra Energy on two "build-own-transfer" agreements to develop and sell a 300 MW wind energy project and to decommission, re-develop, and sell an existing 100 MW wind energy project.

Represented NextEra Energy in its US$1.5bn sale of its FPL FiberNet business to Crown Castle.

Represented Cytyc Corp., a medical device company, in its US$6.2bn merger with Hologic Inc.

Represented Nabi Biopharmaceuticals in its US$251m cross-border business combination with Biota Holdings Ltd., an Australian pharmaceutical company.

Represented NextEra Energy Resources in its US$352m acquisition of three operating wind energy projects from Babcock & Brown.

Represented Orthofix International NV, an orthopedic medical device company, in its US$333m acquisition of Blackstone Medical Inc.

Represented Cytyc Corp. in its US$450m acquisition by tender offer of Adeza Biomedical Corp.

Represented Nabi Biopharmaceuticals in the US$185m sale of its biologics division to Biotest Pharmaceuticals Corp.

Represented Advertising.com Inc., an Internet advertising company, in its US$435m acquisition by America Online Inc.

Represented Musculoskeletal Transplant Foundation Inc., a nonprofit allograft tissue bank, in its unsolicited takeover proposal for Osteotech Inc., a Nasdaq-listed tissue processing company.

Represented Cytyc Corp. in its unsolicited takeover proposal for Vision Systems Ltd., an Australian public company.

Represented McLeodUSA Incorporated in its US$2.1bn acquisition of Splitrock Services Inc., as well as its acquisitions of Ovations Communications and Dakota Telecommunications Group.

Represented Medicis Pharmaceutical, a specialty pharmaceutical company, in its US$300m acquisition (including contingent payments) of LipoSonix Inc.

Represented CSFB as underwriter of CTI Molecular Imaging’s IPO; Liquidity Services in its IPO; McCormick & Co., Cytyc Corp., Oversee.net, and numerous other companies in offerings.

Represented The Advisory Board Company in its US$850m acquisition of Royall & Co.